The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Identification of polo-like kinase 1 (PLK1) in aggressive prostate cancer by paradigm analysis.
Phillip G. Febbo
No relevant relationships to disclose
Theodore C. Goldstein
No relevant relationships to disclose
Robert Baertsch
No relevant relationships to disclose
Jack Youngren
No relevant relationships to disclose
Yulia Newton
No relevant relationships to disclose
Adrian Bivol
No relevant relationships to disclose
Eric Jay Small
No relevant relationships to disclose
Joshua M. Stuart
No relevant relationships to disclose